Literature DB >> 27388719

AU-1 from Agavaceae plants causes transient increase in p21/Cip1 expression in renal adenocarcinoma ACHN cells in an miR-34-dependent manner.

Tomofumi Fujino1, Akihito Yokosuka2, Hideaki Higurashi3, Rina Yokokawa3, Ryo Sakurai3, Wataru Harashima3, Yuichi Miki4, Yasuyuki Fujiwara4, Yoshihiro Mimaki2, Makio Hayakawa3.   

Abstract

Here, we show that AU-1, spirostanol saponin isolated from Agavaceae plants, causes a transient increase in cyclin-dependent kinase inhibitor (CDKI) p21/Cip1 through the upregulation of miRNAs, miR-34 and miR-21. AU-1 stimulated p21/Cip1 expression without exerting cytotoxicity against different types of carcinoma cell lines. In renal adenocarcinoma ACHN cells, AU-1 transiently elevated the expression level of p21/Cip1 protein without marked increases in p21/Cip1 mRNA levels. Rapid and transient increases in miR-34 and miR-21, both of which are known to upregulate p21/Cip1, were observed in AU-1-treated cells. Inhibitor for miR-34 and for miR-21 significantly blocked the AU-1-caused increase in p21/Cip1, indicating that elevation of p21/Cip1 protein by AU-1 is dependent on these microRNAs. We further clarified that NAD-dependent deacetylase SIRT1, a direct target of miR-34, is decreased by the treatment with AU-1. Furthermore, we found that SIRT1-knockdown increases p21/Cip1 protein levels in an miR-21-dependent manner. On the other hand, ectopic expression of p21/Cip1 resulted in the lowered expression of miR-34 and miR-21, suggesting that reciprocal regulation exists between p21/Cip1 and these miRNAs. We propose that the following feedback network composed of miR-34/SIRT1/miR-21/p21 is triggered by the treatment with AU-1: in cells treated with AU-1, transient elevation of miR-34 leads to the downregulation of SIRT1, thereby miR-21 is freed from SIRT1-dependent suppression. Then, elevated miR-21 upregulates p21/Cip1 protein, followed by the suppression of miR-34 expression.

Entities:  

Keywords:  Agave utahensis; SIRT1; miR-21; miR-34; p21/Cip1

Mesh:

Substances:

Year:  2016        PMID: 27388719     DOI: 10.1007/s11418-016-1024-y

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  15 in total

1.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

2.  TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.).

Authors:  Jane Zhao; Paul Lammers; Chris J Torrance; Andreas G Bader
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

Review 3.  MicroRNAs in cancer.

Authors:  Gianpiero Di Leva; Michela Garofalo; Carlo M Croce
Journal:  Annu Rev Pathol       Date:  2013-09-25       Impact factor: 23.472

4.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

5.  Farnesoid X receptor knockdown provides significant growth inhibition in hepatocellular carcinoma cells while it does not interfere with the proliferation of primary human hepatocyte-derived cells.

Authors:  Tomofumi Fujino; Akiko Maruko-Ohtake; Yosuke Ohtake; Tomonori Kobayashi; Ken Ando; Airi Takeuchi; Yasuhito Ohkubo; Makio Hayakawa
Journal:  J Toxicol Sci       Date:  2015-08       Impact factor: 2.196

6.  Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation.

Authors:  Tomofumi Fujino; Airi Takeuchi; Akiko Maruko-Ohtake; Yosuke Ohtake; Junichi Satoh; Tomonori Kobayashi; Toshiaki Tanaka; Haruka Ito; Ryosuke Sakamaki; Ryo Kashimura; Ken Ando; Tomoko Nishimaki-Mogami; Yasuhito Ohkubo; Naomi Kitamura; Ryuichiro Sato; Kiyomi Kikugawa; Makio Hayakawa
Journal:  J Biochem       Date:  2012-09-10       Impact factor: 3.387

7.  Steroidal glycosides from Agave utahensis and their cytotoxic activity.

Authors:  Akihito Yokosuka; Maki Jitsuno; Satoru Yui; Masatoshi Yamazaki; Yoshihiro Mimaki
Journal:  J Nat Prod       Date:  2009-08       Impact factor: 4.050

8.  miR-192 induces G2/M growth arrest in aristolochic acid nephropathy.

Authors:  Robert H Jenkins; Luke C Davies; Philip R Taylor; Hideo Akiyama; Bevan Cumbes; Cristina Beltrami; Christopher P Carrington; Aled O Phillips; Timothy Bowen; Donald J Fraser
Journal:  Am J Pathol       Date:  2014-02-05       Impact factor: 4.307

9.  TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion.

Authors:  Nirmalya Dey; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan.

Authors:  Hanna Dellago; Barbara Preschitz-Kammerhofer; Lucia Terlecki-Zaniewicz; Carina Schreiner; Klaus Fortschegger; Martina W-F Chang; Matthias Hackl; Rossella Monteforte; Harald Kühnel; Markus Schosserer; Florian Gruber; Erwin Tschachler; Marcel Scheideler; Regina Grillari-Voglauer; Johannes Grillari; Matthias Wieser
Journal:  Aging Cell       Date:  2013-04-19       Impact factor: 9.304

View more
  5 in total

1.  AU-1 from Agavaceae plants downregulates the expression of glycolytic enzyme phosphoglycerate mutase.

Authors:  Tomofumi Fujino; Akihito Yokosuka; Harutaka Ichikawa; Toshiyuki Oshima; Yoshihiro Mimaki; Makio Hayakawa
Journal:  J Nat Med       Date:  2017-11-20       Impact factor: 2.343

2.  Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration.

Authors:  Asfar S Azmi; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Sharon Shacham; Michael G Kauffman; Philip A Philip; Ramzi M Mohammad
Journal:  Oncotarget       Date:  2017-07-17

Review 3.  MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.

Authors:  Ammad Ahmad Farooqi; Sobia Tabassum; Aamir Ahmad
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

Review 4.  MicroRNA-34 family in breast cancer: from research to therapeutic potential.

Authors:  Saber Imani; Ray-Chang Wu; Junjiang Fu
Journal:  J Cancer       Date:  2018-09-28       Impact factor: 4.207

Review 5.  Potential Use of Agave Genus in Neuroinflammation Management.

Authors:  Maribel Herrera-Ruiz; Enrique Jiménez-Ferrer; Manasés González-Cortazar; Alejandro Zamilpa; Alexandre Cardoso-Taketa; Martha Lucía Arenas-Ocampo; Antonio Ruperto Jiménez-Aparicio; Nayeli Monterrosas-Brisson
Journal:  Plants (Basel)       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.